Matches in Nanopublications for { ?s ?p "[Because p53 immunopositivity is an adverse prognostic marker in pediatric medulloblastoma and TP53 mutations are associated with chemotherapy and radiation therapy resistance, we aimed to determine the extent and role of TP53 mutations in pediatric medulloblastoma treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_assertion description "[Because p53 immunopositivity is an adverse prognostic marker in pediatric medulloblastoma and TP53 mutations are associated with chemotherapy and radiation therapy resistance, we aimed to determine the extent and role of TP53 mutations in pediatric medulloblastoma treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481164.RASq7wWM5CjeRmcnt-jphV6z-m-fe_ML0kH4j4-JrlCYc130_provenance.
- NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_assertion description "[Because p53 immunopositivity is an adverse prognostic marker in pediatric medulloblastoma and TP53 mutations are associated with chemotherapy and radiation therapy resistance, we aimed to determine the extent and role of TP53 mutations in pediatric medulloblastoma treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_provenance.
- NP792675.RAblKBsUcguP5KH7aouvQym7Man5g8Oc0O0h7ziTYyHrA130_assertion description "[Because p53 immunopositivity is an adverse prognostic marker in pediatric medulloblastoma and TP53 mutations are associated with chemotherapy and radiation therapy resistance, we aimed to determine the extent and role of TP53 mutations in pediatric medulloblastoma treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792675.RAblKBsUcguP5KH7aouvQym7Man5g8Oc0O0h7ziTYyHrA130_provenance.
- assertion description "[Because p53 immunopositivity is an adverse prognostic marker in pediatric medulloblastoma and TP53 mutations are associated with chemotherapy and radiation therapy resistance, we aimed to determine the extent and role of TP53 mutations in pediatric medulloblastoma treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.